Insider Stock Trading History of Castelli Jeff


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Castelli Jeff since year 2005. The trader's CIK number is 1569225. At the time of this reporting, Castelli Jeff is the SVP, Program Management of Amicus Therapeutics Inc . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Castelli Jeff since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-22 FOLD Amicus Therapeutics Inc Option Ex 18,981 13.94 264,633
2015-06-22 FOLD Amicus Therapeutics Inc Sale 18,981 13.94 264,633
2015-06-15 FOLD Amicus Therapeutics Inc Sale 7,377 14.17 104,532
2015-06-08 FOLD Amicus Therapeutics Inc Option Ex 17,312 12.87 222,805
2015-06-08 FOLD Amicus Therapeutics Inc Sale 17,312 12.87 222,805
2015-05-08 FOLD Amicus Therapeutics Inc Option Ex 25,000 .00 0
2015-05-11 FOLD Amicus Therapeutics Inc Sale 10,000 10.84 108,370
2015-04-01 FOLD Amicus Therapeutics Inc Option Ex 9,489 10.70 101,484
2015-04-01 FOLD Amicus Therapeutics Inc Sale 9,489 10.70 101,484
2015-01-05 FOLD Amicus Therapeutics Inc Sale 4,667 9.00 42,003
2015-01-05 FOLD Amicus Therapeutics Inc Option Ex 4,667 9.00 42,003
2014-11-25 FOLD Amicus Therapeutics Inc Buy 8,103 8.00 64,824
2014-11-25 FOLD Amicus Therapeutics Inc Sale 8,103 8.00 64,824
2014-10-03 FOLD Amicus Therapeutics Inc Buy 8,552 7.00 59,864
2014-10-03 FOLD Amicus Therapeutics Inc Sale 8,552 7.00 59,864
2014-10-02 FOLD Amicus Therapeutics Inc Buy 10,208 6.00 61,299
2014-10-02 FOLD Amicus Therapeutics Inc Sale 10,208 6.00 61,299

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Castelli Jeff (SVP, Program Management of Amicus Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.